{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:15:28Z","timestamp":1790306128124,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002749","name":"Belgian Federal Science Policy Office","doi-asserted-by":"publisher","award":["30565447"],"award-info":[{"award-number":["30565447"]}],"id":[{"id":"10.13039\/501100002749","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002749","name":"Belgian Federal Science Policy Office","doi-asserted-by":"publisher","award":["P7\/30"],"award-info":[{"award-number":["P7\/30"]}],"id":[{"id":"10.13039\/501100002749","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007560","name":"Chiesi Farmaceutici","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013276","name":"Interreg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jaip.2021.09.023","type":"journal-article","created":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T12:05:51Z","timestamp":1632398751000},"page":"467-477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Anti\u2013Interleukin-5 Therapy Is Associated with Attenuated Lung Function Decline in Severe Eosinophilic Asthma Patients From the Belgian Severe Asthma Registry"],"prefix":"10.1016","volume":"10","author":[{"given":"Sophie","family":"Graff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Brusselle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane","family":"Hanon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Sohy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieven","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudy","family":"Peche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Michils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Pilette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Joos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lies","family":"Lahousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"Lapperre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Louis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Schleich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2021.09.023_bib1","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1056\/NEJM199810223391703","article-title":"A\u00a015-year follow-up study of ventilatory function in adults with asthma","volume":"339","author":"Lange","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.09.023_bib2","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1183\/09031936.00165106","article-title":"Severe exacerbations predict excess lung function decline in asthma","volume":"30","author":"Bai","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2021.09.023_bib3","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jaip.2017.12.019","article-title":"Asthma exacerbations associated with lung function decline in patients with severe eosinophilic asthma","volume":"6","author":"Ortega","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.09.023_bib4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1183\/09031936.00135907","article-title":"Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma","volume":"32","author":"van Veen","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2021.09.023_bib5","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1164\/rccm.202009-3713OC","article-title":"Mixed sputum granulocyte longitudinal impact on lung function in the Severe Asthma Research Program","volume":"203","author":"Hastie","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2021.09.023_bib6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jaci.2014.04.005","article-title":"Lung function decline and variable airway inflammatory pattern: longitudinal analysis of severe asthma","volume":"134","author":"Newby","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.09.023_bib7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.rmed.2019.04.020","article-title":"Increase in blood eosinophils during follow-up is associated with lung function decline in adult asthma","volume":"152","author":"Graff","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2021.09.023_bib8","doi-asserted-by":"crossref","first-page":"00022","DOI":"10.1183\/23120541.00022-2015","article-title":"Revisiting early intervention in adult asthma","volume":"1","author":"Haahtela","year":"2015","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaip.2021.09.023_bib9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1183\/09031936.00020310","article-title":"on behalf of the P04073 Study Investigators. Mometasone furoate\/formoterol reduces asthma deteriorations and improves lung function","volume":"39","author":"Meltzer","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2021.09.023_bib10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12890-016-0302-5","article-title":"Longitudinal trends in clinical characteristics and lung function of patients with severe asthma under treatment in Brazil","volume":"16","author":"Almeida","year":"2016","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jaip.2021.09.023_bib11","doi-asserted-by":"crossref","first-page":"113944","DOI":"10.1016\/j.bcp.2020.113944","article-title":"Effectiveness of omalizumab on patient reported outcomes, lung function, and inflammatory markers in severe allergic asthma","volume":"179","author":"Frix","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jaip.2021.09.023_bib12","first-page":"PA4901","article-title":"Omalizumab, airway obstruction and remodeling","volume":"48","author":"Bellocchia","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2021.09.023_bib13","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/cea.13601","article-title":"Real-word experience with mepolizumab: does it deliver what it has promised?","volume":"50","author":"Schleich","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2021.09.023_bib14","doi-asserted-by":"crossref","first-page":"00204","DOI":"10.1183\/23120541.00204-2019","article-title":"Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma","volume":"6","author":"Castro","year":"2020","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaip.2021.09.023_bib15","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.jaip.2017.08.024","article-title":"Long-term safety and efficacy of reslizumab in patients with eosinophilic asthma","volume":"5","author":"Murphy","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.09.023_bib16","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","article-title":"Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting \u03b22-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial","volume":"388","author":"Bleecker","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2021.09.023_bib17","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(16)31322-8","article-title":"Benralizumab, an anti-interleukin-5 receptor \u03b1 monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"388","author":"FitzGerald","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2021.09.023_bib18","doi-asserted-by":"crossref","first-page":"1700017","DOI":"10.1183\/13993003.00017-2017","article-title":"Long-term outcomes of bronchial thermoplasty in subjects with severe asthma: a comparison of 3-year follow-up results from two prospective multicentre studies","volume":"50","author":"Chupp","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2021.09.023_bib19","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1164\/rccm.201407-1374LE","article-title":"Reduction of airway smooth muscle mass by bronchial thermoplasty in patients with severe asthma","volume":"190","author":"Pretolani","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2021.09.023_bib20","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1513\/AnnalsATS.201603-182LE","article-title":"Long-term effects of bronchial thermoplasty on airway smooth muscle and reticular basement membrane thickness in severe asthma","volume":"13","author":"Salem","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jaip.2021.09.023_bib21","doi-asserted-by":"crossref","first-page":"1801444","DOI":"10.1183\/13993003.01444-2018","article-title":"Randomised controlled trials in severe asthma: selection by phenotype or stereotype","volume":"52","author":"Brown","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2021.09.023_bib22","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.rmed.2014.10.007","article-title":"Heterogeneity of phenotypes in severe asthmatics. The Belgian Severe Asthma Registry (BSAR)","volume":"108","author":"Schleich","year":"2014","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2021.09.023_bib23","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1164\/ajrccm.162.6.ats9-00","article-title":"Proceedings of the ATS Workshop on Refractory Asthma","volume":"162","author":"Fahy","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2021.09.023_bib24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2021.09.023_bib25","series-title":"Induced Sputum\u2014Towards Normal Values, Non Invasive Assessment of Airways Inflammation in Asthma and COPD","author":"Louis","year":"2011"},{"key":"10.1016\/j.jaip.2021.09.023_bib26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1037\/1082-989X.7.2.147","article-title":"Missing data: our view of the state of the art","volume":"7","author":"Schafer","year":"2002","journal-title":"Psychol Methods"},{"key":"10.1016\/j.jaip.2021.09.023_bib27","author":"Rubin"},{"key":"10.1016\/j.jaip.2021.09.023_bib28","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1164\/ajrccm.161.1.ats11-99","article-title":"Guidelines for methacholine and exercise challenge testing\u20141999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999","volume":"161","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2021.09.023_bib29","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1403291","article-title":"Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma","volume":"371","author":"Bel","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.09.023_bib30","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/arrd.1987.135.4.788","article-title":"The \u2018\u201chorse-racing effect\u201d\u2019 and predicting decline in forced expiratory volume in one second from screening spirometry","volume":"135","author":"Burrows","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaip.2021.09.023_bib31","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1136\/thx.2008.112433","article-title":"Prediction of the rate of decline in FEV(1) in smokers using quantitative computed tomography","volume":"64","author":"Yuan","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2021.09.023_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/thx.40.1.9","article-title":"Bronchial reactivity to inhaled histamine and annual rate of decline in FEV1 in male smokers and ex-smokers","volume":"40","author":"Taylor","year":"1985","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2021.09.023_bib33","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1164\/ajrccm.153.6.8665038","article-title":"Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group","volume":"153","author":"Tashkin","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2021.09.023_bib34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/crj.13325","article-title":"The Omalizumab Italian Study Group, et\u00a0al. Persistence of both reversible airway obstruction and higher blood eosinophils may predict lung function decline in severe asthma","volume":"15","author":"Sposato","year":"2021","journal-title":"Clin Respir J"},{"key":"10.1016\/j.jaip.2021.09.023_bib35","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.iac.2007.09.007","article-title":"Pharmacogenetics of the \u03b22-adrenergic receptor gene","volume":"27","author":"Ortega","year":"2007","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2021.09.023_bib36","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMoa1014350","article-title":"Effect of bronchoconstriction on airway remodeling in asthma","volume":"364","author":"Grainge","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.09.023_bib37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12931-017-0563-4","article-title":"\u03b22 adrenergic agonist suppresses eosinophil-induced epithelial-to-mesenchymal transition of bronchial epithelial cells","volume":"18","author":"Kainuma","year":"2017","journal-title":"Respir Res"},{"key":"10.1016\/j.jaip.2021.09.023_bib38","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.rmed.2015.04.012","article-title":"Lung function impairment increases with age of diagnosis in adult onset asthma","volume":"109","author":"Porsbjerg","year":"2015","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2021.09.023_bib39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaci.2003.10.041","article-title":"Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation","volume":"113","author":"Miranda","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.09.023_bib40","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1164\/rccm.200711-1754OC","article-title":"Cluster analysis and clinical asthma phenotypes","volume":"178","author":"Haldar","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2021.09.023_bib41","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1183\/09059180.00007112","article-title":"Adult-onset asthma: is it really different?","volume":"22","author":"de Nijs","year":"2013","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jaip.2021.09.023_bib42","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0140-6736(02)11679-5","article-title":"Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial","volume":"360","author":"Green","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2021.09.023_bib43","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1164\/ajrccm.164.5.2011026","article-title":"Factors associated with persistent airflow limitation in severe asthma","volume":"164","author":"ten Brinke","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2021.09.023_bib44","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1164\/rccm.200404-440OC","article-title":"\u201cRefractory\u201d eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids","volume":"170","author":"ten Brinke","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2021.09.023_bib45","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)60988-X","article-title":"Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial","volume":"380","author":"Pavord","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2021.09.023_bib46","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1164\/rccm.200208-789OC","article-title":"Eosinophil\u2019s role remains uncertain as anti\u2013interleukin-5 only partially depletes numbers in asthmatic airway","volume":"167","author":"Flood-Page","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2021.09.023_bib47","doi-asserted-by":"crossref","first-page":"106202","DOI":"10.1016\/j.rmed.2020.106202","article-title":"Clinical and biological factors associated with irreversible airway obstruction in adult asthma","volume":"175","author":"Graff","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2021.09.023_bib48","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1080\/02770900500371187","article-title":"Relationship between lung function and asthma symptoms in patients with difficult to control asthma","volume":"42","author":"Aburuz","year":"2005","journal-title":"J\u00a0Asthma"},{"key":"10.1016\/j.jaip.2021.09.023_bib49","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0954-6111(95)90156-6","article-title":"Extrinsic and intrinsic asthma from childhood to adult age: a 10-yr follow-up","volume":"89","author":"Ulrik","year":"1995","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2021.09.023_bib50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1164\/rccm.200402-230OC","article-title":"Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking","volume":"171","author":"James","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2021.09.023_bib51","doi-asserted-by":"crossref","first-page":"1701785","DOI":"10.1183\/13993003.01785-2017","article-title":"Predictors of accelerated decline in lung function in adult-onset asthma","volume":"51","author":"Coumou","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2021.09.023_bib52","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.rmed.2010.03.030","article-title":"Airway eosinophilia in remission and progression of asthma: accumulation with a fast decline of FEV(1)","volume":"104","author":"Broekema","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2021.09.023_bib53","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1183\/09031936.00201813","article-title":"Importance of concomitant local and systemic eosinophilia in uncontrolled asthma","volume":"44","author":"Schleich","year":"2014","journal-title":"Eur Respir J"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821010151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821010151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:30:33Z","timestamp":1761975033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219821010151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2213219821010151"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2021.09.023","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti\u2013Interleukin-5 Therapy Is Associated with Attenuated Lung Function Decline in Severe Eosinophilic Asthma Patients From the Belgian Severe Asthma Registry","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2021.09.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}